Key result
N-acetylprocainamide increases myocardial contraction force, whereas procainamide has a negative inotropic effect.
Why the study?
Does N-acetylprocainamide compared to procainamide affect myocardial contractile force, heart rate, and blood pressure in anesthetized dogs?
Does N-acetylprocainamide compared to procainamide affect myocardial contractile force, heart rate, and blood pressure in anesthetized dogs?
Answers are grounded in this paper and cite their sources.
In a canine model, N-acetylprocainamide demonstrated positive inotropic effects at high doses, contrasting with the negative inotropic effects of procainamide, though both agents lowered heart rate and blood pressure.
The effects of N-acetylprocainamide (NAPA) and procainamide (PA) on myocardial force of contraction were compared in open-chest, vagotomized, pentobarbital-anesthetized dogs, with the use of a Walton-Brodie strain gauge sutured to the right ventricle. NAPA increased myocardial force of contraction, particularly at the high dose level (40 mg/kg). PA, on the other hand, had a negative inotropic effect that was equally apparent at all doses (10-40 mg/kg). In addition, both NAPA and PA had a negative chronotropic effect and caused a reduction in mean arterial pressure. The mechanisms of the inotropic and hypotensive actions of NAPA require elucidation. Some of the implications of these findings for the clinical use of NAPA as an antiarrhythmic agent are discussed.
No takes yet. Share an insight, caveat, or question.
Lertora et al. (1979) studied this question. N-acetylprocainamide (NAPA) vs. Procainamide (PA) was evaluated on Myocardial force of contraction. N-acetylprocainamide increased myocardial force of contraction, particularly at /kg, whereas procainamide had a negative inotropic effect at all doses.
Synapse has enriched 10 related papers. Consider them for comparative context: